KGP-Biotech Consulting, LLC executes cost-effective drug development solutions, and assists virtual companies, small biotechs, and research groups with strategic planning, implementation/execution, project management and lean activities (process improvements) for early-phase assets. 

Ken Payie,  Ph.D., Principal of KGP-Biotech Consulting, LLC, has almost a decade in the large pharma industry in a variety of research and development positions.  With a background in large and small molecule Chemistry Manufacturing & Controls (CM&C) development, virtual drug development experience, and Six Sigma black belt execution, Ken has developed a number of large and small molecule CM&C programs in the Candidate Identification to Phase II space for both large pharma and small drug discovery companies.  Ken has designed and directed drug development programs through outsourcing to Asia, Europe and North American vendors, and dramatically reduced costs to develop assets without compromising Quality.